DBI.AX
DBI.AX
AU0000120628
DALRYMPLE STAPLED [DBI]
Loading chart...
Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 35/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
6/7 High
6 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.3x).

Beta (Market Relation)
0.26x
Defensive
Volatility (5Y p.a.)
22.4% p.a.
5-Year Horizon
Max Drawdown (5Y)
-16.9%
5-Year Horizon
Sharpe Ratio
0.76
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Stable Long-Term Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — +26.9%
3 Years 22.0% -16.9% 1.06 +26.6%
5 Years 22.4% -16.9% 0.76 +19.5%
10 Years — — — —

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Critical leverage: Debt-to-Equity is at 211%.
🔴 High valuation risk: Avg P/E of 79.4 (Elevated multiple compression risk)
Strong cyclicality: The business model is sensitive to economic downturns.
ende